GEN Exclusives

More »

GEN News Highlights

More »
Jun 20, 2008

Intas Biopharmaceuticals Acquires Biologics Process Development

  • Intas Biopharmaceuticals has acquired Biologics Process Development (BPD), based in Poway, California.  BPD provides contract laboratory services in molecular biology, recombinant protein purification and expression, cell culture, bacterial fermentation, cold and frozen cell/material storage, and consulting in biologics process scale-up.

    This acquisition will facilitate Intas Biopharma’s entry into the U.S. market especially in the area of biologics contract research and manufacturing services. Scott M. Brown, founder, president, and CSO of BPD, will stay on in his present role.

    Related Links:

    Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?